Applying quality by design (QbD) concept for fabrication of chitosan coated nanoliposomes

References

• Amin M, Jaafari MR, Tafaghodi M. (2009). Impact of chitosan coating of anionic liposomes on clearance rate, mucosal and systemic immune responses following nasal administration in rabbits. Colloid Surface B 74:225–9
   PubMed Web of Science ®Google Scholar
• Benita S, Poly PA, Puisieux F, Delattre, J. (1984). Radiopaque liposomes: effect of formulation conditions on encapsulation efficiency. J Pharm Sci 73:1751–5
   PubMed Web of Science ®Google Scholar
• Bolhuis G, Duineveld CAA, Boer JH, Coenegracht PMJ. (1995). Simultaneous optimization of multiple criteria in tablet formulation: part I. Pharm Technol Eur 8:42–50
   Google Scholar
• Cabral ECM, Zollner RL, Santana MHA. (2004). Preparation and characterization of liposomes entrapping allergenic proteins. Braz J Chem Eng 21:137–46
   Web of Science ®Google Scholar
• Chiraz JM, Roudayna D, Veronique A, et al. (2010). Ethanol injection method for hydrophilic and lipophilic drug-loaded liposome preparation. J Liposome Res 20:228–43
   PubMedGoogle Scholar
• Corvo ML, Boerman OC, Oyen WJ, et al. (2000). Subcutaneous administration of superoxide dismutase entrapped in long circulating liposomes: in vivo fate and therapeutic activity in an inflammation model. Pharm Res 17:600–6
   PubMed Web of Science ®Google Scholar
• Fan M, Xu S, Xia S, Zhang X. (2008). Preparation of salidroside nano-liposomes by ethanol injection method and in vitro release study. Eur Food Res Technol 227:167–74
   Web of Science ®Google Scholar
• Grit M, Underberg WJM, Crommelin DJA. (1993). Hydrolysis of saturated soybean phosphatidylcholine in aqueous liposome dispersions. J Pharm Sci 82:362–6
   PubMed Web of Science ®Google Scholar
• Guo J, Ping Q, Jiang G, et al. (2003). Chitosan-coated liposomes: characterization and interaction with leuprolide. Int J Pharm 260:167–73
   PubMed Web of Science ®Google Scholar
• Hwang RC, Geemoules MK, Ramlose DS, Thomason CE. (1998). A systematic formulation optimization process for a generic pharmaceutical tablet. Pharm Technol 22:48–64
   Google Scholar
• Hwang SY, Kima HK, Choo J, et al. (2012). Effects of operating parameters on the efficiency of liposomal encapsulation of enzymes. Colloid Surface B 94:296–303
   PubMed Web of Science ®Google Scholar
• ICH harmonised tripartite guideline (November 2005). Quality Risk Management Q9, 3--19
   Google Scholar
• ICH harmonised tripartite guideline (2005). Quality Risk Management Q9, 3--19
   Google Scholar
• ICH harmonised tripartite guideline (2006). Guidance for Industry, Pharmaceutical Development Q8, 6--7
   Google Scholar
• ICH, Draft consensus guideline: pharmaceutical development annex to Q8 (2008), 2--10
   Google Scholar
• Justo OR, Moraes AM. (2011). Analysis of process parameters on the characteristics of liposomes prepared by ethanol injection with a view to process scale-up: effect of temperature and batch volume. Chem Eng Res Des 8 9:785–92
   Google Scholar
• Kirby C, Clarke J, Gregoriadis G. (1980). Effect of the cholesterol content of small unilamellar liposomes on their stability in vivo and in vitro. Biochem J 186:591--8
   PubMed Web of Science ®Google Scholar
• Lee SC, Lee KE, Kim JJ, Lim SH. (2005). The effect of cholesterol in the liposome bilayer on the stabilization of incorporated retinol. J Liposome Res 15:157–66
   PubMed Web of Science ®Google Scholar
• Lindberg NO, Lundstedt T. (1995). Application of multivariate analysis in pharmaceutical development work. Drug Dev Ind Pharm 21:987–1007
   Web of Science ®Google Scholar
• Mady MM, Darwish MM. (2010). Effect of chitosan coating on the characteristics of DPPC liposomes. J Adv Res 1:187–91
   Google Scholar
• Maitani Y, Soeda H, Junping W, Takayama K. (2001). Modified ethanol injection method for liposomes containing β-sitosterol β-d-glucoside. J Liposome Res 11:115–25
   PubMed Web of Science ®Google Scholar
• Mennini N, Furlanetto S, Cirri M, Mura P. (2012). Quality by design approach for developing chitosan-Ca-alginate microspheres for colon delivery of celecoxib-hydroxypropyl-b-cyclodextrin-PVP complex. Eur J Pharm Biopharm 80:67–75
   PubMed Web of Science ®Google Scholar
• Naelapaa K, Alleso M, Kristensen HG, et al. (2008). Increasing process understanding by analyzing complex interactions in experimental data. J Pharm Sci 98:1852–61
   Google Scholar
• Naseem AC, Areeg AA, Shamsherb ASZ, Ziyaur R. (2012). Quality by design approach for formulation development: a case study of dispersible tablets. Int J Pharm 423:167–78
   PubMedGoogle Scholar
• Stewart DJ. (1974). Sensitive automated methods for phosphate and (Na+ + K+)-ATPase. Anal Biochem 62:349–64
   PubMedGoogle Scholar
• Szoka FC. (1996). Preparation of liposome and lipid complex compositions. United States Patent 5549910
   Google Scholar
• Szoka F, Papahadjopoulos D. (1978). Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. Proc Natl Acad Sci USA 75:4194–8
   PubMed Web of Science ®Google Scholar
• Trummer BJ, Iyer V, Iyer SVB, et al. (2012). Physicochemical properties of epidermal growth factor receptor inhibitors and development of a nanoliposomal formulation of gefitinib. J Pharm Sci 101:2763–76
   PubMed Web of Science ®Google Scholar
• Voinovich D, Campisi B, Moneghini M, et al. (1999). Screening of high shear mixer melt granulation process variables using an asymmetrical factorial design. Int J Pharm 190:73–81
   PubMed Web of Science ®Google Scholar
• Woodle MC. (1995). Sterically stabilized liposome therapeutics. Adv Drug Deliv Rev 16:249–65
   Web of Science ®Google Scholar
• Xu X, Khan MA, Burgess DJ. (2011). A quality by design. (QbD) case study on liposomes containing hydrophilic API: I formulation, processing design and risk assessment. Int J Pharm 419:52–9
   PubMed Web of Science ®Google Scholar
• Xu X, Khan MA, Burgess DJ. (2012). A quality by design. (QbD) case study on liposomes containing hydrophilic API: II Screening of critical variables, and establishment of design space at laboratory scale. Int J Pharm 423:543–53
   PubMed Web of Science ®Google Scholar